Matthew Parker to Risk Assessment
This is a "connection" page, showing publications Matthew Parker has written about Risk Assessment.
Connection Strength
0.232
-
Kohn CG, Mearns ES, Parker MW, Hernandez AV, Coleman CI. Prognostic accuracy of clinical prediction rules for early post-pulmonary embolism all-cause mortality: a bivariate meta-analysis. Chest. 2015 Apr; 147(4):1043-1062.
Score: 0.067
-
Rai M, Baker WL, Parker MW, Heller GV. Meta-analysis of optimal risk stratification in patients >65 years of age. Am J Cardiol. 2012 Oct 15; 110(8):1092-9.
Score: 0.056
-
Parker MW, Thompson PD. Assessment and management of atherosclerosis in the athletic patient. Prog Cardiovasc Dis. 2012 Mar-Apr; 54(5):416-22.
Score: 0.054
-
Hamel AP, Orwig T, Tran BN, Vogt B, Senser E, Hegde S, Kovell L, Lee JA, Parker MW, Fitzgibbons T, McManus DD, Tran KT. Epicardial fat is associated with prevalent heart failure and adverse cardiac remodeling in atrial fibrillation. BMC Cardiovasc Disord. 2026 Jun 13; 26(1).
Score: 0.037
-
Chaudhry W, Hussain N, Ahlberg AW, Croft LB, Fernandez AB, Parker MW, Swales HH, Slomka PJ, Henzlova MJ, Duvall WL. Multicenter evaluation of stress-first myocardial perfusion image triage by nuclear technologists and automated quantification. J Nucl Cardiol. 2017 06; 24(3):809-820.
Score: 0.018